| abstract |
The purpose of the present invention is to provide a novel drug based on epigenetics control. The present invention relates to a histone demethylase inhibitor constituted of a compound represented by formula (I) [symbols in the formula are as defined in the specification], or a pharmaceutically acceptable salt thereof, or a tautomer thereof, and also relates to a prophylactic and/or therapeutic drug that contains the histone demethylase inhibitor, and that is for diseases triggered by increased histone demethylase reactivity. |